Bendamustine formulations
AssigneeInnoPharma Licensing, LLC
InventorsUdaya Toti, Kumaresh Soppimath, Rekha Nayak, Satish Pejaver, Navneet Puri
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnoPharma Licensing, LLC
InventorsUdaya Toti, Kumaresh Soppimath, Rekha Nayak, Satish Pejaver, Navneet Puri
Estimating the term…
A lyophilized bendamustine composition consisting of bendamustine hydrochloride, an aqueous solvent, and optionally an excipient, and a method of preparation thereof for treating a condition in a subject are provided. The aqueous solvent includes, for example, water, an acid, a base, or a salt, etc. The excipient includes at least one cryoprotectant, for example, sucrose, trehalose, mannitol, etc. A pre-lyophilization bendamustine composition is lyophilized, for example, by freezing, primary drying, annealing, secondary drying, condensed cooling and evacuation at preset temperatures to obtain the lyophilized bendamustine composition as a cake, a powder, or a solid concentrate. The lyophilized bendamustine composition is free of a non-aqueous solvent. Reconstitution is performed by mixing the lyophilized bendamustine composition with an aqueous solvent for about 30 seconds to 300 seconds. The reconstituted bendamustine product containing about 0.2 wt % to about 2.5 wt % by weight of impurities is administered to the subject in need thereof.
A method for preparing a stable lyophilized bendamustine composition for treating a condition in a subject in need thereof, comprising:
Dependencies are inferred from the claim text.